Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression
about
Current medical treatment of estrogen receptor-positive breast cancerNovel Strategies to Improve the Endocrine Therapy of Breast Cancer.Mechanistic Effects of Calcitriol in Cancer BiologyBreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo.Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanismsLentivirus-mediated Knockdown of HDAC1 Uncovers Its Role in Esophageal Cancer Metastasis and Chemosensitivity.LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMPRole of steroid receptor and coregulator mutations in hormone-dependent cancers.Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.HDACs and HDAC Inhibitors in Cancer Development and Therapy.The role of fulvestrant in endometrial cancer.Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer.Emerging data on improving response to hormone therapy: the role of novel targeted agents.HDAC inhibition potentiates immunotherapy in triple negative breast cancer.TdIF1: a putative oncogene in NSCLC tumor progression
P2860
Q26795751-40A397E4-4B22-49EA-A2B0-D92746980415Q33727284-F24C0D05-DB89-44AF-A8B2-1F138AC5D5ABQ35809076-5E424BB5-1AAD-4A9B-B40D-FA430D0213DFQ36283422-467356E9-168D-42A4-973F-3ABAC3D0D577Q36751705-746D5B05-18A2-423B-A1DF-EA7F16D7EE60Q37290559-12C4B2DF-825F-4B51-AA03-84C70ECD7300Q37336908-F8216838-9C02-4A9C-B098-4A33672A7507Q38736287-614A5A08-163B-4F67-B79A-B567FFEEC677Q38747536-AD7CA63C-EC52-492A-94F0-3673623AF3AFQ38947405-35493D66-4A49-4AA0-B0BA-1040EF340906Q38970776-52C47E9D-A64A-45A8-AD0D-DF55298C022DQ39434758-770692EE-845E-4EB5-A790-DAF1D0394C1AQ46537162-E17EA6E0-CD2F-4A05-836E-7E8DEC82ACD4Q48522970-4A6B0022-5DB9-4B73-A1B1-9C545B5118A9Q57811691-E33FDF26-B83B-4141-AB41-DE4EFF23366B
P2860
Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Combined histone deacetylase i ...... reversing Bcl-2 overexpression
@ast
Combined histone deacetylase i ...... reversing Bcl-2 overexpression
@en
type
label
Combined histone deacetylase i ...... reversing Bcl-2 overexpression
@ast
Combined histone deacetylase i ...... reversing Bcl-2 overexpression
@en
prefLabel
Combined histone deacetylase i ...... reversing Bcl-2 overexpression
@ast
Combined histone deacetylase i ...... reversing Bcl-2 overexpression
@en
P2093
P2860
P1476
Combined histone deacetylase i ...... reversing Bcl-2 overexpression
@en
P2093
Jeenah Park
K Ted Thurn
Pamela N Munster
Paromita Raha
Scott Thomas
P2860
P2888
P356
10.1186/S13058-015-0533-Z
P577
2015-02-25T00:00:00Z
P5875
P6179
1049624305